Cargando…

Circulating microRNAs in Fabry Disease

Fabry disease is an X-linked deficiency of the lysosomal hydrolase alpha-galactosidase A (alpha-Gal). This results in an accumulation of globotriaosylceramide (GL-3/Gb3) in a variety of cells with subsequent functional impairment. The continuous progress of FD often leads to decreased quality of lif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Ke, Lu, Dongchao, Hoepfner, Jeannine, Santer, Laura, Gupta, Shashi, Pfanne, Angelika, Thum, Sabrina, Lenders, Malte, Brand, Eva, Nordbeck, Peter, Thum, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813291/ https://www.ncbi.nlm.nih.gov/pubmed/31649303 http://dx.doi.org/10.1038/s41598-019-51805-6

Ejemplares similares

MicroRNAs in Serum and Bile of Patients with Primary Sclerosing Cholangitis and/or Cholangiocarcinoma
por: Voigtländer, Torsten, et al.
Publicado: (2015)

MicroRNAs regulating superoxide dismutase 2 are new circulating biomarkers of heart failure
por: Dubois-Deruy, Emilie, et al.
Publicado: (2017)

MicroRNAs as novel peripheral markers for suicidality in patients with major depressive disorder
por: Stapel, Britta, et al.
Publicado: (2022)

Publisher Correction: MicroRNAs regulating superoxide dismutase 2 are new circulating biomarkers of heart failure
por: Dubois-Deruy, Emilie, et al.
Publicado: (2018)

Circulating MicroRNAs Are Not Eliminated by Hemodialysis
por: Martino, Filippo, et al.
Publicado: (2012)

MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes
por: Lu, Dongchao, et al.
Publicado: (2020)

Blood-based microRNA profiling in patients with cardiac amyloidosis
por: Derda, Anselm A., et al.
Publicado: (2018)

Fabry Disease: The Current Treatment Landscape
por: Lenders, Malte, et al.
Publicado: (2021)

Fabry disease – a multisystemic disease with gastrointestinal manifestations
por: Lenders, Malte, et al.
Publicado: (2022)

In Vitro and In Vivo Amenability to Migalastat in Fabry Disease
por: Lenders, Malte, et al.
Publicado: (2020)

Assessment and impact of dose escalation on anti-drug antibodies in Fabry disease
por: Lenders, Malte, et al.
Publicado: (2022)

Circulating cardiovascular microRNAs in critically ill COVID‐19 patients
por: Garg, Ankita, et al.
Publicado: (2021)

Microparticles and MicroRNAs of Endothelial Progenitor Cells Ameliorate AKI
por: Bitzer, Markus, et al.
Publicado: (2012)

Circulating microRNAs in Symptomatic and Asymptomatic Carotid Stenosis
por: Grosse, Gerrit M., et al.
Publicado: (2021)

MicroRNA therapeutics in cardiovascular medicine
por: Thum, Thomas
Publicado: (2012)

A pilot study of circulating microRNAs as potential biomarkers of Fabry disease
por: Cammarata, Giuseppe, et al.
Publicado: (2018)

MicroRNAs bei COVID-19: kleine Moleküle mit großem Potenzial?
por: Bär, Christian, et al.
Publicado: (2021)

MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure
por: Watson, Chris J, et al.
Publicado: (2015)

Studying Interactions between 2’-O-Me-Modified Inhibitors and MicroRNAs Utilizing Microscale Thermophoresis
por: Herkt, Markus, et al.
Publicado: (2019)

Circulating microRNAs and Outcome in Patients with Acute Heart Failure
por: Seronde, Marie-France, et al.
Publicado: (2015)

Neutralizing anti-drug antibodies in Fabry disease have no obvious clinical impact?
por: Lenders, Malte, et al.
Publicado: (2018)

Mechanisms of Neutralizing Anti-drug Antibody Formation and Clinical Relevance on Therapeutic Efficacy of Enzyme Replacement Therapies in Fabry Disease
por: Lenders, Malte, et al.
Publicado: (2021)

Endothelial Dysfunction in Fabry Disease Is Related to Glycocalyx Degradation
por: Pollmann, Solvey, et al.
Publicado: (2021)

Identification of cell and disease specific microRNAs in glomerular pathologies
por: Müller‐Deile, Janina, et al.
Publicado: (2019)

Pre-existing anti-drug antibodies in Fabry disease show less affinity for pegunigalsidase alfa
por: Lenders, Malte, et al.
Publicado: (2022)

Characterization of pre-existing anti-PEG and anti-AGAL antibodies towards PRX-102 in patients with Fabry disease
por: Lenders, Malte, et al.
Publicado: (2023)

Circulating microRNAs for predicting and monitoring response to mechanical circulatory support from a left ventricular assist device
por: Morley-Smith, Andrew C, et al.
Publicado: (2014)

Serum circular RNAs act as blood-based biomarkers for hypertrophic obstructive cardiomyopathy
por: Sonnenschein, Kristina, et al.
Publicado: (2019)

Circulating micrornas as potential biomarkers of aerobic exercise capacity
por: Mooren, Frank C., et al.
Publicado: (2013)

Circulating microRNAs predispose to takotsubo syndrome following high-dose adrenaline exposure
por: Couch, Liam S, et al.
Publicado: (2021)

A signature of circulating microRNAs differentiates takotsubo cardiomyopathy from acute myocardial infarction
por: Jaguszewski, Milosz, et al.
Publicado: (2014)

MicroRNAs as systemic biomarkers to assess distress in animal models for gastrointestinal diseases
por: Kumstel, Simone, et al.
Publicado: (2020)

Impact of enzyme replacement therapy and migalastat on left atrial strain and cardiomyopathy in patients with Fabry disease
por: Pogoda, Christian, et al.
Publicado: (2023)

MicroRNA-22 increases senescence and activates cardiac fibroblasts in the aging heart
por: Jazbutyte, Virginija, et al.
Publicado: (2012)

Circulating microRNAs in aging
por: Bonafè, Massimiliano, et al.
Publicado: (2015)

Circulating microRNAs in Medicine
por: Pozniak, Tetiana, et al.
Publicado: (2022)

Therapeutic modulation of RNA-binding protein Rbm38 facilitates re-endothelialization after arterial injury
por: Sonnenschein, Kristina, et al.
Publicado: (2019)

Circulating microRNAs in Patients with Shiga-Toxin-Producing E. coli O104:H4 Induced Hemolytic Uremic Syndrome
por: Lorenzen, Johan M., et al.
Publicado: (2012)

MicroRNAs in diabetic cardiomyopathy and clinical perspectives
por: Zhou, Qiulian, et al.
Publicado: (2014)

Multicenter Female Fabry Study (MFFS) - clinical survey on current treatment of females with Fabry disease
por: Lenders, Malte, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bm21k77dvrj13fua5fmgbvlg3u